Invention Grant
US09072750B2 Use of prostaglandins F2Alpha and analogues for the healing of corneal and conjunctival lesions
有权
使用前列腺素F2Alpha和类似物治疗角膜和结膜病变
- Patent Title: Use of prostaglandins F2Alpha and analogues for the healing of corneal and conjunctival lesions
- Patent Title (中): 使用前列腺素F2Alpha和类似物治疗角膜和结膜病变
-
Application No.: US13510884Application Date: 2010-11-19
-
Publication No.: US09072750B2Publication Date: 2015-07-07
- Inventor: Jean-Sébastien Garrigue , Frédéric Lallemand , Philippe Daull , Christophe Baudouin
- Applicant: Jean-Sébastien Garrigue , Frédéric Lallemand , Philippe Daull , Christophe Baudouin
- Applicant Address: FR Evry
- Assignee: SANTEN SAS
- Current Assignee: SANTEN SAS
- Current Assignee Address: FR Evry
- Agency: Norton Rose Fulbright US LLP
- Priority: EP10164376 20100528
- International Application: PCT/EP2010/067846 WO 20101119
- International Announcement: WO2011/061298 WO 20110526
- Main IPC: A61K31/5575
- IPC: A61K31/5575 ; A61K31/216 ; A61K9/00 ; A61K9/107 ; A61K45/06 ; A61K47/10 ; A61K47/18 ; A61K47/26
Abstract:
The invention relates to a composition for use in treating corneal and conjunctival lesions, wherein the composition comprises a prostaglandin F2alpha or analogue, in a therapeutic amount, said composition being in a form suitable for topical application on the ocular surface and is free of deleterious preservative; the invention also relates to a method for treating surface ocular conditions in a patient in need thereof, comprising administering a composition of the invention.
Public/Granted literature
- US20120225939A1 Use of Prostaglandins F2Alpha and Analogues for the Healing of Corneal and Conjunctival Lesions Public/Granted day:2012-09-06
Information query
